Clinical Trial Update: CoSeal in Liver and Biliary Surgery in Prevention of Denovo Hepatic Adhesion [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating CoSeal to prevent new hepatic adhesions during liver and biliary surgery in patients with liver metastases has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases

Drugs mentioned

• COSEAL

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Patient With Hepatic Metastasis | Phase 2, Phase 3 | Status: TERMINATED